株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ハイコンテントスクリーニング (HCS) の世界市場:2015〜2019年

Global High Content Screening (HCS) Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 334060
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。
Back to Top
ハイコンテントスクリーニング (HCS) の世界市場:2015〜2019年 Global High Content Screening (HCS) Market 2015-2019
出版日: 2015年07月01日 ページ情報: 英文 76 Pages
概要

ハイコンテントスクリーニング (HCS) 技術は単一細胞レベルで画像に基づく多重パラメーター解析を行なう技術であり、当初は創薬における生物学的ハイスループットスクリーニングを補完するために開発されました。HCSは細胞試料の表現型の変化を解析します。世界のハイコンテントスクリーニング市場は、2014〜2019年にかけCAGR11.53%で拡大すると予測されています。

当レポートでは、世界のハイコンテントスクリーニング (HCS) 市場について詳細に分析し、市場の動向と2015〜2019年の成長見通し、エンドユーザー別、地域別動向、および主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 当レポートの範囲

第4章 市場調査方法

第5章 イントロダクション

第6章 重要動向

第7章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第8章 エンドユーザー別市場セグメンテーション

第9章 地域別セグメンテーション

  • 地域別市場セグメンテーション
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 購入基準

第11章 市場成長促進因子

第12章 促進因子とその影響

第13章 市場の課題

第14章 促進因子と課題の影響

第15章 市場動向

第16章 動向とその影響

第17章 ベンダー環境

  • 競合シナリオ
  • 市場シェア調査:2014年
  • その他の将来的見込みのあるベンダー

第18章 主要ベンダー調査

  • Becton, Dickinson and Co.
  • GE Healthcare
  • Danaher
  • PerkinElmer
  • Thermo Fisher Scientific

第19章 当シリーズの他のレポート

図表

目次
Product Code: IRTNTR6483

About HCS

High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.

Technavio's analysts forecast the global HCS market to grow at a CAGR of 11.53% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global HCS market for the period 2015-2019. The market can be segmented into three customer segments: Pharmaceutical and biotechnology companies, academia and research institutes, and contract research organizations.

Technavio's report, Global HCS Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global HCS market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Becton, Dickinson and Company
  • GE Healthcare
  • Danaher
  • PerkinElmer
  • Thermo Fisher Scientific

Other Prominent Vendors

  • Blue Sky Bioservices
  • Cell Signaling Technology
  • Charles River Laboratories International
  • Cytoo
  • EMD Millipore
  • Evotec
  • Fluofarma
  • Genedata
  • Imagen Biotech
  • Thorlabs
  • Tecan
  • Vala Sciences
  • Wako Automation
  • Yokogawa

Key Market Driver

  • Growing Importance of High Content Screening in Therapeutics
  • For a full, detailed list, view our report

Key Market Challenge

  • Handling Large Amount of Data
  • For a full, detailed list, view our report

Key Market Trend

  • Advances in Personalized Medicines
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Key Developments

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by End-User

09. Geographical Segmentation

  • 09.1. Segmentation of Global HCS Market by Region
  • 09.2. HCS Market in Americas
    • 09.2.1. Market Size and Forecast
  • 09.3. HCS Market in EMEA
    • 09.3.1. Market Size and Forecast
  • 09.4. HCS Market in APAC
    • 09.4.1. Market Size and Forecast

10. Buying Criteria

11. Market Drivers

12. Drivers and Their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and Their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2014
    • 17.2.1. BD
    • 17.2.2. GE Healthcare
    • 17.2.3. Molecular Devices (Subsidiary of Danaher)
    • 17.2.4. PerkinElmer
    • 17.2.5. Thermo Fisher Scientific
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Becton, Dickinson and Co.
    • 18.1.1. Key Facts
    • 18.1.2. Business Description
    • 18.1.3. Business Segmentation
    • 18.1.4. Revenue Segmentation by Business
    • 18.1.5. Segmental Revenue Comparison 2013 and 2012
    • 18.1.6. Revenue Segmentation by Region
    • 18.1.7. Business Strategy
    • 18.1.8. Key Developments
    • 18.1.9. SWOT Analysis
  • 18.2. GE Healthcare
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Strategy
    • 18.2.5. Key Developments
    • 18.2.6. SWOT Analysis
  • 18.3. Danaher
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation
    • 18.3.4. Revenue by Business Segmentation
    • 18.3.5. Revenue Comparison 2012 and 2013
    • 18.3.6. Segmentation by Region
    • 18.3.7. Business Strategy
    • 18.3.8. Key Information
    • 18.3.9. SWOT Analysis
  • 18.4. PerkinElmer
    • 18.4.1. Key Facts
    • 18.4.2. Business Description
    • 18.4.3. Business Segmentation
    • 18.4.4. Business Strategy
    • 18.4.5. Revenue Segmentation by Business
    • 18.4.6. Key Developments
    • 18.4.7. SWOT Analysis
  • 18.5. Thermo Fisher Scientific
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Segmentation by Revenue 2014
    • 18.5.4. Business Segmentation by Revenue 2013 and 2014
    • 18.5.5. Geographical Segmentation by Revenue 2014
    • 18.5.6. Business Strategy
    • 18.5.7. Recent Developments
    • 18.5.8. SWOT Analysis

19. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Advantages of HCS over Traditional Technologies
  • Exhibit 3: Global HCS Market 2014-2019 ($ millions)
  • Exhibit 4: Segmentation of Global HCS Market by End-User
  • Exhibit 5: Segmentation of Global HCS Market by End-User 2014
  • Exhibit 6: Segmentation of Global HCS Market by Region 2014
  • Exhibit 7: HCS Market in Americas 2014-2019 ($ millions)
  • Exhibit 8: HCS Market in EMEA 2014-2019 ($ millions)
  • Exhibit 9: HCS Market in APAC 2014-2019 ($ millions)
  • Exhibit 10: Pros and Cons of IN Cell Analyzer 2000
  • Exhibit 11: Pros and Cons of ImageXpress Micro Widefield (Standard) and Image Xpress Micro Widefield XL
  • Exhibit 12: Pros and Cons of Opera
  • Exhibit 13: Pros and Cons of Operetta
  • Exhibit 14: Product Categorization of Becton, Dickinson and Co.
  • Exhibit 15: Revenue Segmentation of Becton, Dickinson and Co. 2013
  • Exhibit 16: Revenue Comparison ($ millions)
  • Exhibit 17: Revenue Segmentation of Becton, Dickinson and Co. by Region 2013
  • Exhibit 18: GE Healthcare: Business Segmentation 2013
  • Exhibit 19: Danaher: Business Segmentation
  • Exhibit 20: Danaher: Business Segmentation 2013
  • Exhibit 21: Danaher: Revenue by Business Segmentation 2012 and 2013 ($ millions)
  • Exhibit 22: Danaher: Revenue by Geographical Segmentation 2013
  • Exhibit 23: PerkinElmer: Business Segmentation 2013
  • Exhibit 24: PerkinElmer: Revenue Segmentation 2013
  • Exhibit 25: PerkinElmer: Revenue by Business Segments 2013 and 2012 ($ billions)
  • Exhibit 26: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
  • Exhibit 27: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billions)
  • Exhibit 28: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014
Back to Top